Trademark: 88826046
Word
ERMEZA
Status
Registered
Status Code
700
Status Date
Tuesday, March 28, 2023
Serial Number
88826046
Registration Number
7012836
Registration Date
Tuesday, March 28, 2023
Mark Type
4000
Filing Date
Monday, March 9, 2020
Published for Opposition
Tuesday, July 7, 2020

Trademark Owner History
Mylan Pharmaceuticals, Inc. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of thyroid disorders

Trademark Events
Mar 28, 2023
Notice Of Registration Confirmation Emailed
Mar 28, 2023
Registered-Principal Register
Feb 22, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 21, 2023
Allowed Principal Register - Sou Accepted
Jan 22, 2023
Statement Of Use Processing Complete
Dec 20, 2022
Use Amendment Filed
Jan 22, 2023
Case Assigned To Intent To Use Paralegal
Dec 20, 2022
Teas Statement Of Use Received
Sep 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2022
Sou Extension 4 Granted
Aug 31, 2022
Sou Extension 4 Filed
Aug 31, 2022
Teas Extension Received
Mar 3, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 28, 2022
Sou Extension 3 Granted
Feb 28, 2022
Sou Extension 3 Filed
Feb 28, 2022
Teas Extension Received
Sep 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2021
Sou Extension 2 Granted
Aug 31, 2021
Sou Extension 2 Filed
Aug 31, 2021
Teas Extension Received
Mar 2, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 26, 2021
Sou Extension 1 Granted
Feb 26, 2021
Sou Extension 1 Filed
Feb 26, 2021
Teas Extension Received
Sep 1, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 7, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 7, 2020
Published For Opposition
Jun 17, 2020
Notification Of Notice Of Publication E-Mailed
May 29, 2020
Approved For Pub - Principal Register
May 29, 2020
Assigned To Examiner
Mar 13, 2020
New Application Office Supplied Data Entered
Mar 12, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24